Ra Capital Management, L.P. - Aug 18, 2023 Form 4 Insider Report for AN2 Therapeutics, Inc. (ANTX)

Role
10%+ Owner
Signature
/s/ Peter Kolchinsky, Manager of RA Capital Management, L.P.
Stock symbol
ANTX
Transactions as of
Aug 18, 2023
Transactions value $
$16,000,002
Form type
4
Date filed
8/22/2023, 05:01 PM
Previous filing
Aug 9, 2023
Next filing
Aug 31, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANTX Common Stock Purchase $16M +1.78M +52.94% $9.00 5.14M Aug 18, 2023 See Footnotes F1, F2, F3
holding ANTX Common Stock 416K Aug 18, 2023 See Footnotes F2, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Acquired from the Issuer pursuant to the public offering described in the Issuer's Prospectus filed with the Securities and Exchange Commission on August 16, 2023.
F2 RA Capital Management, L.P. (the "Adviser") is the investment manager for RA Capital Healthcare Fund, L.P. (the "Fund") and RA Capital Nexus Fund II, L.P. (the "Nexus Fund II"). The general partner of the Adviser is RA Capital Management GP, LLC (the "Adviser GP"), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members. The Adviser, the Adviser GP, Dr. Kolchinsky, and Mr. Shah disclaim beneficial ownership of any of the reported securities, except to the extent of their pecuniary interest therein.
F3 Held directly by the Fund.
F4 Held directly by the Nexus Fund II.